The Union Health Ministry has reclassified the neurological drug Pregabalin under Schedule H1 to combat rising youth misuse and illegal sales. This mandates valid prescriptions, three-year sales record retention, and aims to curb unregulated online deliveries.
Click to View MorePeptide therapies, especially GLP-1 agonists for diabetes and obesity, are gaining popularity beyond medical use. While medically beneficial, their misuse as lifestyle drugs through unregulated online markets raises health risks. India must strengthen CDSCO regulation and awareness to balance innovation, safety, and responsible use.
Click to View More
© 2026 iasgyan. All right reserved
